About GD

This author has not yet filled in any details.
So far GD has created 14 blog entries.

Bronze sponsor at the Swedish National Conference of Urology 2018

2023-01-21T15:54:34+01:00October 2018|

Bronze sponsor at the Swedish National Conference of Urology 2018 Every year, the Swedish Association of Urology organizes a national conference where about 1 000 participants from all over Sweden gather to share urological science and experience. This year Cernelle hosted a Bronze sponsorship at the conference in Umeå, Sweden. Associate Professors Ralph Peeker and Hans Hedelin attracted around 150 urologists and nurses to their seminar about Chronic Pelvic Pain Syndrome (CPPS); “Chronic pelvic pain syndrome. What do we know and what do we think we know?” Cernitol® Novum an OTC classified drug in Sweden was presented in the [Read more]

AB CERNELLE sponsors the Swedish Association of Urology in Gothenburg.

2023-01-21T15:55:11+01:00October 2017|

AB CERNELLE sponsors the Swedish Association of Urology in Gothenburg. Cernitol, a herbal pharmaceutical medicine to treat symptoms caused by benign prostate diseases. Has been more and more recognised in Sweden as an effective and safe alternative to use. During the national conference in Gothenburg organized by the Swedish Association of Urology, AB Cernelle is awarded as Bronze sponsor. Associate Professors Magnus Grabe and Hans Hedelin will lead a seminar about the role of inflammation i the prostate gland and whether this contribute to the development of Lower Urinary Tract Symptoms (LUTS) and chronic pelvic pain? More information: Ken [Read more]

Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome

2023-08-28T12:06:26+02:00August 2015|

Giuseppe Magistro, Florian M.E. Wagenlehner, Magnus Grabe, Wolfgang Weidner, Christian G. Stief, J. Curtis Nickel Context: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition that causes severe symptoms, bother, and quality-of-life impact in the 8.2% of men who are believed to be affected. Research suggests a complex pathophysiology underlying this syndrome that is mirrored by its heterogeneous clinical presentation. Management of patients diagnosed with CP/CPPS has always been a formidable task in clinical practice. Due to its enigmatic etiology, a plethora of clinical trials failed to identify an efficient monotherapy. READ MORE

Cernilton in Patients with Inflammatory Chronic Prostatitis–Chronic Pelvic Pain Syndrome

2023-08-28T12:07:00+02:00June 2009|

Florian M.E. Wagenlehner, Henning Schneider, Martin Ludwig, Jörg Schnitker, Elmar Brähler, Wolfgang Weidner A Pollen Extract (Cernilton) in Patients with Inflammatory Chronic Prostatitis–Chronic Pelvic Pain Syndrome: A Multicentre, Randomised, Prospective, Double-Blind, Placebo-Controlled Phase 3 Study. Background: National Institutes of Health (NIH) category III prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent condition for which no standardised treatment exists. Objectives: To assess the safety and efficacy of a standardised pollen extract in men with inflammatory CP/CPPS. READ MORE

Go to Top